Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment
MD Anderson Head and Neck Symptom Working Group, Laia Humbert-Vidan, Serageldin Kamel, Andrew Wentzel, Zaphanlene Kaffey, Moamen Abdelaal, Kyle B. Spier, Natalie A. West, G. Elisabeta Marai, Guadalupe Canahuate, Xinhua Zhang, Melissa M. Chen, Kareem A. Wahid, Jillian Rigert, Seyedmohammadhossein Hosseinian, Andrew J. Schaefer, Kristy K. Brock, Mark Chambers, Adegbenga O. Otun, Ruth Aponte-Wesson, Vinod Patel, Andrew Hope, Jack Phan, Adam S. Garden, Steven J. Frank, William H Morrison, Michael T Spiotto, David Rosenthal, Anna Lee, Renjie He, Mohamed A. Naser, Erin Watson, Katherine A. Hutcheson, Abdallah S. R. Mohamed, Vlad C. Sandulache, Lisanne V. van Dijk, Amy C. Moreno, Teresa Guerrero Urbano, Stephen Y. Lai, Clifton D. Fuller
medRxiv 2024.08.20.24312311; doi: https://doi.org/10.1101/2024.08.20.24312311
